Reakcje niepożądane po zastosowaniu środków kontrastowych – aktualny stan wiedzy. Część 1. Charakterystyka środków kontrastowych, rodzaje i obraz kliniczny reakcji niepożądanych

##plugins.themes.bootstrap3.article.main##

Beata Sadowska
Agnieszka Lipiec

Abstrakt

W pracy przedstawiono aktualny stan wiedzy na temat reakcji niepożądanych po zastosowaniu środków kontrastowych; zarówno reakcji nadwrażliwości, jak i toksycznych. Omówiono m.in. obecnie stosowane jodowe środki kontrastowe i preparaty zawierające gadolin. Autorki odwołują się do wielu opublikowanych badań oceniających częstość występowania reakcji niepożądanych po zastosowaniu tych preparatów. Opisany został również obraz kliniczny i zarys patomechanizmu reakcji niepożądanych.

Pobrania

Dane pobrania nie są jeszcze dostepne

##plugins.themes.bootstrap3.article.details##

Jak cytować
Sadowska , B., & Lipiec , A. (2017). Reakcje niepożądane po zastosowaniu środków kontrastowych – aktualny stan wiedzy. Część 1. Charakterystyka środków kontrastowych, rodzaje i obraz kliniczny reakcji niepożądanych. Alergoprofil, 13(1), 13-22. Pobrano z https://journalsmededu.pl/index.php/alergoprofil/article/view/172
Dział
Artykuł

Bibliografia

1. Andreucci M., Faga T., Pisani A. et al.: The Choice of the Iodinated Radiographic Contrast Media to Prevent Contrast-Induced Nephropathy. Advances in Nefrology 2014 [http://dx.doi.org/10.1155/2014/691623].
2. Andreucci M., Solomon R., Tasanarong A.: Side effects of radiographic contrast media: Pathogenesis, risk factors, and prevention. Biomed. Res. Int. 2014, DOI: 10.1155/2014/741018.
3. Davis P.L.: Anaphylactoid reactions to the nonvascular administration of water-soluble iodinated contrast media. Am. J. Roentgenol. 2015, 204(6): 1140-1145.
4. Brockow K., Christiansen C., Kanny G. et al.: Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005, 60(2): 150-158.
5. Lapi F., Cecchi E., Pedone C. et al.: Safety aspects of iodinated contrast media related to their physicochemical properties: A pharmacoepidemiology study in two Tuscany hospitals. Eur. J. Clin. Pharmacol. 2008, 64(7): 723-737.
6. ACR Committee M on CD and C. Manual on Contrast Media, v. 10.1., 2015 [online: http://www.acr.org/~/media/ACR/ Documents/PDF/QualitySafety/Resources/Contrast Manual/ 2015_Contrast_Media.pdf].
7. Egbert R.E., De Cecco C.N., Schoepf U.J. et al.: Delayed adverse reactions to the parenteral administration of iodinated contrast media. Am. J. Roentgenol. 2014, 203(6): 1163-1170.
8. Brockow K., Sánchez-Borges M.: Hypersensitivity to Contrast Media and Dyes. Immunol. Allergy Clin. North Am. 2014, 34(3): 547-564.
9. Brockow K., Romano A., Aberer W. et al.: Skin testing in patients with hypersensitivity reactions to iodinated contrast media – A European multicenter study. Allergy 2009, 64(2): 234-241.
10. Rosado Ingelmo A., Diaz D.I., Moreno C.R. et al.: Clinical Practice Guidelines for Diagnosis and Management of Hypersensitivity Reactions to Contrast Media. J. Investig. Allergol. Clin. Immunol. 2016, 26(263): 144-155.
11. Mortelé K.J., Oliva M.R., Ondategui S. et al.: Universal use of nonionic iodinated contrast medium for CT: Evaluation of safety in a large urban teaching hospital. Am. J. Roentgenol. 2005, 184(1): 31-34.
12. Solomon R.: Contrast media: Are there differences in nephrotoxicity among contrast media? Biomed. Res. Int. 2014, DOI: 10.1155/2014/934947.
13. Mozaffarian D., Benjamin E.J., Go A.S. et al.: Heart Disease and Stroke Statistics – 2015 Update: A Report From the American Heart Association. Circulation 2015, 131(4): e29 322. DOI: 10.1161/CIR.0000000000000152.
14. Yoon S.H., Lee S.Y., Kang H.R. et al.: Skin tests in patients with hypersensitivity reaction to iodinated contrast media: a meta-analysis. Allergy 2015, 70(6): 625-637.
15. Siddiqi N.H. Contrast Medium Reaction [online: http://emedicine.medscape.com/article/422855-overview].
16. Lerondeau B., Trechot P., Waton J. et al.: Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions. J. Allergy Clin. Immunol. 2016, 137(2): 633-635.
17. Lieberman P.L., Seigle R.L.: Reactions to radiocontrast material: Anaphylactoid events in radiology. Clin. Rev. Allergy Immunol. 1999, 17: 469-496.
18. Dong M., Jiao Z., Liu T. et al.: Effect of administration route on the renal safety of contrast agents: A meta-analysis of randomized controlled trials. J. Nephrol. 2012, 25(3): 290-301.
19. Granata V., Cascella M., Fusco R. et al.: Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations. BioMed Res. Int. 2016 [Article ID 3918292: http://dx.doi.org/10.1155/2016/3918292].
20. Ramalho J., Semelka R.C., Ramalho M. et al.: Gadolinium-based contrast agent accumulation and toxicity: An update. Am. J. Neuroradiol. 2016, 37(7): 1192-1198.
21. European Society of Urogenital Radiology, ESUR Guidelines on Contrast Media. V. 9.0. European Society of Urogenital Radiology, 2015 [online: http://www.esur.org/guidelines].
22. Brockow K., Christiansen C., Kanny G. et al.: Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005, 60(2): 150-158.
23. Wang C.L., Cohan R.H., Ellis J.H. et al.: Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. Am. J. Roentgenol. 2008, 191(2): 409-415.
24. Motosugi U., Ichikawa T., Sano K., Onishi H.: Acute Adverse Reactions to Nonionic Iodinated Contrast Media for CT: Prospective Randomized Evaluation of the Effects of Dehydration, Oral Rehydration, and Patient Risk Factors. Am. J. Roentgenol. 2016, 207: DOI: 10.2214/AJR.16.16051.
25. Cochran S.T., Bomyea K., Sayre J.W.: Trends in adverse events after IV administration of contrast media. Am. J. Roentgenol. 2001, 176: 1385-1388.
26. Kopp A.F., Mortele K.J., Cho Y.D. et al.: Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients. Acta Radiol. 2008, 49(8): 902-911.
27. Hunt C.H., Hartman R.P., Hesley G.K.: Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: Retrospective review of 456,930 doses. Am. J. Roentgenol. 2009, 193(4): 1124-1127.
28. Bush W.H., Swanson D.P.: Acute reactions to intravascular contrast media: Types, risk factors, recognition, and specific treatment. Am. J. Roentgenol. 1991, 157(6): 1153-1161.
29. Katayma H.: Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990, 175: 621-628.
30. Greenberger P.A., Patterson R.: The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J. Allergy Clin. Immunol. 1991, 87(4): 867-872.
31. Caro J.J., Trindade E., McGregor M.: The risks of death and of severe nonfatal reactions with high-vs low-osmolality contrast media: A meta-analysis. Am. J. Roentgenol. 1991, 156(4): 825-832.
32. Lasser E.C., Lyon S.G., Berry C.C.: Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology 1997, 203(3): 605-610.
33. Dillman J.R., Strouse P.J., Ellis J.H. et al.: Incidence and severity of acute allergic-like reactions to IV nonionic iodinated contrast material in children. Am. J. Roentgenol. 2007, 188(6): 1643-1647.
34. Callahan M.J., Poznauskis L., Zurakowski D., Taylor G.A.: Nonionic Iodinated Intravenous Contrast Material-related Reactions: Incidence in Large Urban Children’s Hospital – Retrospective Analysis of Data in 12 494 Patients. Radiology 2009, 250(3): 674-681.
35. Freed K.S., Leder R.A., Alexander C. et al.: Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. Am. J. Roentgenol. 2001, 176(6): 1389-1392.
36. Yamaguchi K., Katayama H., Takashima T. et al.: Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1991, 178(2): 363-367.
37. Egbert R.E., De Cecco C.N., Schoepf U.J. et al.: Delayed adverse reactions to the parenteral administration of iodinated contrast media. Am. J. Roentgenol. 2014, 203(6): 1163-1170.
38. Jung J.W., Kang H.R., Kim M.H. et al.: Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology 2012, 264(2): 414-422.
39. Fakhran S., Alhilali L., Kale H., Kanal E.: Assessment of rates of acute adverse reactions to gadobenate dimeglumine: review of more than 130,000 administrations in 7.5 years. AJR Am. J. Roentgenol. 2015, 204(4): 703-706.
40. Dillman J.R., Ellis J.H., Cohan R.H. et al.: Frequency and severity of acute allergic-like reactions to gadolinium-containing IV contrast media in children and adults. Am. J. Roentgenol. 2007, 189(6): 1533-1538.
41. Dunnick N.R., Cohan R.H.: Cost, corticosteroids, and contrast media. Am. J. Roentgenol. 1994, 162: 527-529.
42. Christiansen C., Pichler W.J., Skotland T.: Delayed allergy-like reactions to X-ray contrast media: Mechanistic considerations. Eur. Radiol. 2000, 10(12): 1965-1975.
43. Webb J.W., Stacul F., Thomsen H.S., Morcos S.K.: Late adverse reactions to intravascular iodinated contrast media. Eur. Radiol. 2003, 13(1): 181-184.
44. Brockow K.: Contrast media hypersensitivity – scope of the problem. Toxicology 2005, 209: 189-192.
45. Loh S., Bagheri S., Katzberg R.W. et al.: Delayed adverse reaction to contrast-enhanced CT: a prospective single-center study comparison to control group without enhancement. Radiology 2010, 255(3): 764-771.
46. Vernassiere C., Trechot P., Commun N. et al.: Low negative predictive value of skin tests in investigating delayed reactions to radio-contrast media. Contact Dermatitis 2004, 50(6): 359-366.
47. Meth M.J., Maibach H.I.: Current understanding of contrast media reactions and implications for clinical management. Drug Saf. 2006, 29(2): 133-141.
48. Choyke P.L., Miller D.L., Lotze M.T. et al.: Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 1992, 183(1): 111-114.
49. Schild H.H., Kuhl C.K., Hubner-Steiner U. et al.: Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial. Radiology 2006, 240(1): 56-64.
50. Sutton A.G.C., Finn P., Grech E.D. et al.: Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am. Heart J. 2001, 141(4): 677-683.
51. Sutton A.G., Finn P., Campbell P.G. et al.: Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization. J. Invasive Cardiol. 2003, 15: 133-138.
52. Savill J.S., Barrie R., Ghosh S. et al.: Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus. Postgrad. Med. J. 1988, 64(751): 392-394.
53. Laffitte E., Nenadov Beck M., Hofer M. et al.: Severe Stevens-Johnson syndrome induced by contrast medium iopentol (Imagopaque). Br. J. Dermatol. 2004, 150: 376-378.
54. Atasoy M., Erdem T., Sari R.A.: A case of acute generalized exanthematous pustulosis (AGEP) possibly induced by iohexol. J. Dermatol. 2003, 30: 723-726.
55. Peterson A., Katzberg R.W., Fung M.A. et al.: Acute generalized exanthematous pustulosis as a delayed dermatotoxic reaction to IV-administered nonionic contrast media. Am. J. Roentgenol. 2006, 187: 198-201.
56. Hammerbeck A.A., Daniels N.H., Callen J.P.: Ioversol-induced acute generalized exanthematous pustulosis: a case report. Arch. Dermatol. 2009, 145: 683-687.
57. Poliak N., Elias M., Cianferoni A., Treat J.: Acute generalized exanthematous pustulosis: the first pediatric case caused by a contrast agent. Ann. Allergy Asthma Immunol. 2010, 105: 242-243.
58. Rhee C.M., Bhan I., Alexander E.K., Brunelli S.M.: Association Between Iodinated Contrast Media Exposure and Incident Hyperthyroidism and Hypothyroidism. Arch. Intern. Med. 2012, 172(2): 153-159.
59. Lakhal K., Ehrmann S., Chaari A. et al.: Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: Incidence and outcome. J. Crit. Care 2011, 26(6): 593-599.
60. Mehran R., Nikolsky E.: Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int. Suppl. 2006, 69(100): S11-S15.
61. Solomon R.: Contrast-Induced Acute Kidney Injury (CIAKI). Radiol. Clin. North Am. 2009, 47(5): 783-788.
62. Gleeson T., Bulugahapitiya S.: Contrast-induced nephropathy. Am. J. Roentgenol. 2004, 183(6): 1673-1689.
63. Tsushima Y., Ishiguchi T., Murakami T. et al.: Safe use of iodinated and gadolinium-based contrast media in current practice in Japan: a questionnaire survey. Jpn. J. Radiol. 2016, 34(2): 130-139.
64. Gilgen-Anner Y., Heim M., Ledermann H.P., Bircher A.J.: Iodide mumps after contrast media imaging: a rare adverse effect to iodine. Ann. Allergy Asthma Immunol. 2007, 99(1): 93-98.
65. Donnelly P.K., Williams B., Watkin E.M.: Polyarthropathy – a delayed reaction to low osmolality angiographic contrast medium in patients with end stage renal disease. Eur. J. Radiol. 1993, 17(2): 130-132.
66. Morcos S.K.: Acute serious and fatal reactions to contrast media: Our current understanding. Br. J. Radiol. 2005, 78(932): 686-693.
67. Lasser E.C.: The multipotential pseudoantigenicity of X-ray contrast media: Pseudoantigen excess may downregulate the release of hypotensive mediators. Int. Arch. Allergy Immunol. 2000, 123(4): 282-290.
68. Laroche D., Aimone-Gastin I., Dubois F. et al.: Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 1998, 209(1): 183-190.
69. Bouachour G., Varache N., Szapiro N. et al.: Noncardiogenic pulmonary edema resulting from intravascular administration of contrast material. Am. J. Roentgenol. 1991, 157: 255-256.
70. Gómez E., Ariza A., Blanca-López N., Torres M.J.: Nonimmediate hypersensitivity reactions to iodinated contrast media. Curr. Opin. Allergy Clin. Immunol. 2013, 13(4): 345-353.
71. Kanny G., Pichler W., Morisset M. et al.: T cell-mediated reactions to iodinated contrast media: Evaluation by skin and lymphocyte activation tests. J. Allergy Clin. Immunol. 2005, 115(1): 179-185.
72. Galera C., Ozygit L.P., Cavigioli S. et al.: Gadoteridol-induced anaphylaxis – not a class allergy. Allergy 2010, 65(1): 132-134.